SCHEMBL13637249

SCHEMBL13637249

CC[C@H]1OC(=O)[C@H](C)[C@@H](O)[C@H](C)[C@@H](O)[C@@H](C)C[C@@H](C)C[C@@H](C)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13792939 0.99
SCHEMBL14543966 0.92
SCHEMBL12266551 0.92
SCHEMBL16015994 0.92
SCHEMBL13105405 0.86
SCHEMBL15450664 0.86 MLNR (0.30)
SCHEMBL14080237 0.83
SCHEMBL14000791 0.82
SCHEMBL14389168 0.81 DAGLA (0.32)
SCHEMBL15450659 0.80 LMNA (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286291-A1 BORRELIDIN-PRODUCING POLYKETIDE SYNTHASE AND ITS USE SALAS JOSE A 2009-11-19 US disclosed
US-7560252-B2 Borrelidin-producing polyketide synthase and its use BIOTICA TECHNOLOGY LIMITED (GB) 2009-07-14 US disclosed
US-20070065920-A1 For treatment of microbial conditions (including malaria), proliferative disorders, inappropiate vascularisation, inhibition of angiogenesis; THE UNIVERSITY OF OVIEDO (ES) 2007-03-22 US disclosed